Skip to content

International Union of Quaternary Research (INQUA), INQUA – Commission on Stratigraphy and Chronology (SACCOM)

Scientific Abstracts, qPCR, PCR, RT-PCR, cDNA, RNA

Menu
  • Home
  • Isotype
  • peptide
  • Lenti
  • elisa kits
  • antibody
  • Distributors
  • vector
  • cDNA
  • Contact Us
Menu
inqua-saccom

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Posted on April 29, 2021 by Leah

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

A recent report that 93 per cent of invasive cervical cancers worldwide contain human papillomavirus (HPV) may be an underestimate, due to sample inadequacy or integration events affecting the HPV L1 gene, which is the target of the polymerase chain reaction (PCR)-based test which was used. The formerly HPV-negative cases from this study have therefore been reanalyzed for HPV serum antibodies and HPV DNA. Serology for HPV 16 VLPs, E6, and E7 antibodies was performed on 49 of the 66 cases which were HPV-negative and a sample of 48 of the 866 cases which were HPV-positive in the original study.
Moreover, 55 of the 66 formerly HPV-negative biopsies were also reanalyzed by a sandwich procedure in which the outer sections in a series of sections are used for histological review, while the inner sections are assayed by three different HPV PCR assays targeting different open reading frames (ORFs). No significant difference was found in serology for HPV 16 proteins between the cases that were originally HPV PCR-negative and -positive. Type-specific E7 PCR for 14 high-risk HPV types detected HPV DNA in 38 (69 per cent) of the 55 originally HPV-negative and amplifiable specimens. The HPV types detected were 16, 18, 31, 33, 39, 45, 52, and 58. Two (4 per cent) additional cases were only HPV DNA-positive by E1 and/or L1 consensus PCR. Histological analysis of the 55 specimens revealed that 21 were qualitatively inadequate. Only two of the 34 adequate samples were HPV-negative on all PCR tests, as against 13 of the 21 that were inadequate ( p< 0.001).
inqua-saccom
inqua-saccom
Combining the data from this and the previous study and excluding inadequate specimens, the worldwide HPV prevalence in cervical carcinomas is 99.7 per cent. The presence of HPV in virtually all cervical cancers implies the highest worldwide attributable fraction so far reported for a specific cause of any major human cancer. The extreme rarity of HPV-negative cancers reinforces the rationale for HPV testing in addition to, or even instead of, cervical cytology in routine cervical screening.

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.

In December, 2019, a pneumonia associated with the 2019 novel coronavirus (2019-nCoV) emerged in Wuhan, China. We aimed to further clarify the epidemiological and clinical characteristics of 2019-nCoV pneumonia.In this retrospective, single-centre study, we included all confirmed cases of 2019-nCoV in Wuhan Jinyintan Hospital from Jan 1 to Jan 20, 2020. Cases were confirmed by real-time RT-PCR and were analysed for epidemiological, demographic, clinical, and radiological features and laboratory data. Outcomes were followed up until Jan 25, 2020.Of the 99 patients with 2019-nCoV pneumonia, 49 (49%) had a history of exposure to the Huanan seafood market.
The average age of the patients was 55·5 years (SD 13·1), including 67 men and 32 women. 2019-nCoV was detected in all patients by real-time RT-PCR. 50 (51%) patients had chronic diseases. Patients had clinical manifestations of fever (82 [83%] patients), cough (81 [82%] patients), shortness of breath (31 [31%] patients), muscle ache (11 [11%] patients), confusion (nine [9%] patients), headache (eight [8%] patients), sore throat (five [5%] patients), rhinorrhoea (four [4%] patients), chest pain (two [2%] patients), diarrhoea (two [2%] patients), and nausea and vomiting (one [1%] patient).
According to imaging examination, 74 (75%) patients showed bilateral pneumonia, 14 (14%) patients showed multiple mottling and ground-glass opacity, and one (1%) patient had pneumothorax. 17 (17%) patients developed acute respiratory distress syndrome and, among them, 11 (11%) patients worsened in a short period of time and died of multiple organ failure.The 2019-nCoV infection was of clustering onset, is more likely to affect older males with comorbidities, and can result in severe and even fatal respiratory diseases such as acute respiratory distress syndrome. In general, characteristics of patients who died were in line with the MuLBSTA score, an early warning model for predicting mortality in viral pneumonia. Further investigation is needed to explore the applicability of the MuLBSTA score in predicting the risk of mortality in 2019-nCoV infection.National Key R&D Program of China.

AFLP: a new technique for DNA fingerprinting.

A novel DNA fingerprinting technique called AFLP is described. The AFLP technique is based on the selective PCR amplification of restriction fragments from a total digest of genomic DNA. The technique involves three steps: (i) restriction of the DNA and ligation of oligonucleotide adapters, (ii) selective amplification of sets of restriction fragments, and (iii) gel analysis of the amplified fragments.
PCR amplification of restriction fragments is achieved by using the adapter and restriction site sequence as target sites for primer annealing. The selective amplification is achieved by the use of primers that extend into the restriction fragments, amplifying only those fragments in which the primer extensions match the nucleotides flanking the restriction sites. Using this method, sets of restriction fragments may be visualized by PCR without knowledge of nucleotide sequence. The method allows the specific co-amplification of high numbers of restriction fragments. The number of fragments that can be analyzed simultaneously, however, is dependent on the resolution of the detection system. Typically 50-100 restriction fragments are amplified and detected on denaturing polyacrylamide gels. The AFLP technique provides a novel and very powerful DNA fingerprinting technique for DNAs of any origin or complexity.

Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets.

Accurate normalization is an absolute prerequisite for correct measurement of gene expression. For quantitative real-time reverse transcription-PCR (RT-PCR), the most commonly used normalization strategy involves standardization to a single constitutively expressed control gene. However, in recent years, it has become clear that no single gene is constitutively expressed in all cell types and under all experimental conditions, implying that the expression stability of the intended control gene has to be verified before each experiment.
We outline a novel, innovative, and robust strategy to identify stably expressed genes among a set of candidate normalization genes. The strategy is rooted in a mathematical model of gene expression that enables estimation not only of the overall variation of the candidate normalization genes but also of the variation between sample subgroups of the sample set.
Notably, the strategy provides a direct measure for the estimated expression variation, enabling the user to evaluate the systematic error introduced when using the gene. In a side-by-side comparison with a previously published strategy, our model-based approach performed in a more robust manner and showed less sensitivity toward coregulation of the candidate normalization genes. We used the model-based strategy to identify genes suited to normalize quantitative RT-PCR data from colon cancer and bladder cancer. These genes are UBC, GAPD, and TPT1 for the colon and HSPCB, TEGT, and ATP5B for the bladder. The presented strategy can be applied to evaluate the suitability of any normalization gene candidate in any kind of experimental design and should allow more reliable normalization of RT-PCR data.

cDNA - Human Adult Normal Tissue: Uterus: Fundus

C1234278-10 Biochain 10 reactions
EUR 215

cDNA - Monkey (Rhesus) Normal Tissue: Uterus: Cervix

C1534275 Biochain 40 reactions
EUR 578

cDNA - Monkey (Rhesus) Normal Tissue: Uterus: Corpus

C1534276 Biochain 40 reactions
EUR 578

cDNA - Monkey (Rhesus) Normal Tissue: Uterus: Fundus

C1534278 Biochain 40 reactions
EUR 578

cDNA - Monkey (Cynomolgus) Normal Tissue: Uterus: Cervix

C1534275-Cy Biochain 40 reactions
EUR 578

Total RNA - Human Adult Normal Tissue: Uterus: Cervix of uterus

R1234275-50 Biochain 50 ug
EUR 170

Total RNA - Human Adult Normal Tissue: Uterus: Corpus of Uterus

R1234276-10 Biochain 10 ug
EUR 191

Fetal Uterus Lysate

XBL-10431 ProSci 0.1 mg
EUR 632.4
Description: Fetal human uterus tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The fetal human uterus tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the uterus tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The uterus tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Uterus Membrane Lysate

XBL-11023 ProSci 0.1 mg
EUR 619.8
Description: Human uterus tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human uterus tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated uterus tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated uterus tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal.

Bovine UTERUS 5 EA*

57153-2 Pel-Freez 5 EA
EUR 245.04

Total RNA - Lupus: Uterus

R1236274Lup-50 Biochain 50 ug
EUR 421.2

Human Uterus Tumor lysate

HTL-1384 Alpha Diagnostics 1 mg
EUR 927.6

Uterus tumor tissue array

UT802a TissueArray each
EUR 306
Description: Uterus tumor tissue array, including stromal and leiomyo sarcoma, endometrioid adenocarcinoma, chorionepithelioma, hydatidiform mole, clear cell carcinoma, carcinsarcoma, sarcomatoid carcinoma, with pathology grade, TNM/Stage (AJCC 8th edition), 80 cases/80 cores (cores size 1.5mm), replacing UT802

Rabbit UTERUS Y 25 EA*

41253-2 Pel-Freez 25 EA
EUR 382.07

Uterus Tissue Slide (Normal)

11-401-10um ProSci 10 um
EUR 241.8

Uterus Tissue Slide (Normal)

11-401-4um ProSci 4 um
EUR 216.6

Uterus Tissue Slide (Benign)

11-402-10um ProSci 10 um
EUR 241.8

Uterus Tissue Slide (Benign)

11-402-4um ProSci 4 um
EUR 216.6

Total RNA - Human Adult Normal Tissue 5 Donor Pool: Uterus: Cervix of uterus

R1234275-P Biochain 50 ug
EUR 370

Uterus Tissue Slide (Abnormal)

11-419-10um ProSci 10 um
EUR 241.8

Uterus Tissue Slide (Abnormal)

11-419-4um ProSci 4 um
EUR 216.6

Uterus Membrane Tumor Lysate

XBL-11031 ProSci 0.1 mg
EUR 752.1
Description: Human uterus tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human uterus tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated uterus tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated uterus tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal.

Uterus Tissue Slide (Adenomyoma)

11-432-10um ProSci 10 um
EUR 241.8

Uterus Tissue Slide (Adenomyoma)

11-432-4um ProSci 4 um
EUR 216.6

Uterus-Corpus Membrane Lysate

XBL-11037 ProSci 0.1 mg
EUR 619.8
Description: Human uterus-corpus tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human uterus-corpus tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated uterus-corpus tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated uterus-corpus tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal.

Uterus-Fundus Membrane Lysate

XBL-11040 ProSci 0.1 mg
EUR 619.8
Description: Human uterus-fundus tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human uterus-fundus tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated uterus-fundus tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated uterus-fundus tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal.

Uterus Tissue Slide (Adenocarcinoma)

11-404-10um ProSci 10 um
EUR 241.8

Uterus Tissue Slide (Adenocarcinoma)

11-404-4um ProSci 4 um
EUR 216.6

Uterus cancer test tissue array

T093 TissueArray each
EUR 78
Description: Uterus cancer test tissue array, with normal endometrial tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores

Leiomyoma of uterus tissue array

SO806 TissueArray each
EUR 270
Description: Leiomyoma of uterus tissue array, 80 cases/80 cores

Total RNA - Human Tumor Tissue: Uterus

R1235274-50 Biochain 50 ug
EUR 400

Uterus Tissue Slide (Spindle Cell Tumor)

11-418-10um ProSci 10 um
EUR 241.8

Uterus Tissue Slide (Spindle Cell Tumor)

11-418-4um ProSci 4 um
EUR 216.6

Total Protein - Human Tumor Tissue: Uterus

P1235274 Biochain 1 mg
EUR 310

Frozen Tissue Section - Human Tumor: Uterus

T1235274 Biochain 5 slides
EUR 330

Membrane Protein - Human Tumor Tissue: Uterus

P3235274 Biochain 0.1 mg
EUR 410

Uterus Tissue Slide (Endometrioid Adenocarcinoma)

11-405-10um ProSci 10 um
EUR 241.8

Uterus Tissue Slide (Endometrioid Adenocarcinoma)

11-405-4um ProSci 4 um
EUR 216.6

FFPE Genomic DNA - Human Tumor Tissue: Uterus

D2235274 Biochain 2 ug
EUR 960

Total RNA - Human Adult Normal Tissue: Uterus

R1234274-50 Biochain 50 ug
EUR 170

Human Adult Uterus (Normal) Whole tissue lysate

HAL-1317 Alpha Diagnostics 1 mg
EUR 628.8

Monkey (Cyno.) Normal Uterus Whole tissue lysate

MCL-1222 Alpha Diagnostics 1 mg
EUR 927.6

Total Protein - Human Adult Normal Tissue: Uterus

P1234274 Biochain 1 mg
EUR 188

Monkey (Rhesus) Normal Uterus Whole tissue lysate

MRL-1332 Alpha Diagnostics 1 mg
EUR 927.6

Frozen Tissue Section - Human Adult Normal: Uterus

T1234274 Biochain 5 slides
EUR 343

Genomic DNA - Lupus: Uterus, from a single donor

D1236274Lup Biochain 50 ug
EUR 504

Human Uterus Tissue Slide (Normal) (5 slides/pk)

HTS-11401 Alpha Diagnostics 1 pk
EUR 343.2

Human Uterus Tissue Slide (Benign) (5 slides/pk)

HTS-11402 Alpha Diagnostics 1 pk
EUR 343.2

Uterus Tissue Slide ( Papillary serous Adenocarcinoma)

11-407-10um ProSci 10 um
EUR 241.8

Uterus Tissue Slide ( Papillary serous Adenocarcinoma)

11-407-4um ProSci 4 um
EUR 216.6

Membrane Protein - Human Adult Normal Tissue: Uterus

P3234274 Biochain 0.1 mg
EUR 270

Paraffin Tissue Section - Human Uterus Cervix Tumor

T2235275 Biochain 5 slides
EUR 238

Paraffin Tissue Section - Human Adult Normal: Uterus

T2234274 Biochain 5 slides
EUR 185

Human Uterus Tissue Slide (Abnormal) (5 slides/pk)

HTS-11419 Alpha Diagnostics 1 pk
EUR 343.2

Human Uterus Tissue Slide (Adenomyoma) (5 slides/pk)

HTS-11432 Alpha Diagnostics 1 pk
EUR 343.2

Human Uterus Tissue Slide (Adenocarcinoma) (5 slides/pk)

HTS-11404 Alpha Diagnostics 1 pk
EUR 343.2

Total Protein - Human Adult Normal Tissue: Uterus: Cervix

P1234275 Biochain 1 mg
EUR 188

Total Protein - Human Adult Normal Tissue: Uterus: Corpus

P1234276 Biochain 1 mg
EUR 188

Total Protein - Human Adult Normal Tissue: Uterus: Fundus

P1234278 Biochain 1 mg
EUR 188

Multiple of uterus cancer with endometrium tissue array

UT1501a TissueArray each
EUR 258
Description: Multiple of uterus cancer with endometrium tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores, replacing UT1501

Membrane Protein - Human Adult Normal Tissue: Uterus: Corpus

P3234276 Biochain 0.1 mg
EUR 270

Membrane Protein - Human Adult Normal Tissue: Uterus: Fundus

P3234278 Biochain 0.1 mg
EUR 270

Total RNA - Human Adult Normal Tissue 5 Donor Pool: Uterus

R1234274-P Biochain 50 ug
EUR 370

Human Uterus Tissue Slide (Spindle cell tumor) (5 slides/pk)

HTS-11418 Alpha Diagnostics 1 pk
EUR 343.2

Rat Normal Uterus (single section per slide) (5 slides/pack)

RaFPT041 TissueArray 5 slides
EUR 150

Paraffin Tissue Section - Human Uterus Tumor: Adenocarcinoma, MSS

T2235274MSS Biochain 5 slides
EUR 524

Normal Human Uterus (single section per slide) (5 slides/pack)

HuFPT096 TissueArray 5 slides
EUR 150

Paraffin Tissue Section - Human Uterus Cervix Tumor, HPV positive

T2235275HPV+ Biochain 5 slides
EUR 646.8
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.

Paraffin Tissue Section - Human Uterus Cervix Tumor, HPV negative

T2235275HPV- Biochain 5 slides
EUR 646.8
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.

Paraffin Tissue Section - Human Uterus Cervix Tumor, HPV negative

T2235275HPV-negative Biochain 5 slides
EUR 524

Paraffin Tissue Section - Human Uterus Cervix Tumor, HPV positive

T2235275HPV-positive Biochain 5 slides
EUR 524

Cynomolgus Monkey: Uterus (single section per slide) (5 slides/pack)

CyFPT081 TissueArray 5 slides
EUR 150

Human Uterus Tissue Slide (Endometrioid Adenocarcinoma) (5 slides/pk)

HTS-11405 Alpha Diagnostics 1 pk
EUR 343.2

Paraffin Tissue Section - Human Uterus Tumor: Endometrium Adenocarcinoma

T2235274-3 Biochain 5 slides
EUR 238

Genomic DNA - Human Tumor Tissue: Uterus Tumor, from a single donor

D1235274 Biochain 50 ug
EUR 489

Genomic DNA - Human Adult Normal Tissue: Uterus, from a single donor

D1234274 Biochain 100 ug
EUR 286

Human Uterus Tissue Slide (Papillary serous Adenocarcinoma) (5 slides/pk)

HTS-11407 Alpha Diagnostics 1 pk
EUR 343.2

Genomic DNA - Human Adult Normal Tissue: Uterus: Cervix, from a single donor

D1234275 Biochain 100 ug
EUR 286

Multiple Tumor Tissue Array - Bladder, Colon, Kidney, Lung, Stomach, and Uterus tumors

T8235716d-2 Biochain 2 slides
EUR 295

Multiple Tumor Tissue Array - Ovary, Bladder, Breast, Kidney, Uterus, and Lung tumors, plus 12 tumor/normal pairs

T8235714d-2 Biochain 2 slides
EUR 295

Multiple Tumor Tissue Array - Ovary, Bladder, Breast, Kidney, Uterus, and Lung tumors, plus 12 tumor/normal pairs

T8235714d-5 Biochain 5 slides
EUR 606

Multiple Tumor Tissue Array - Bladder, Colon, Kidney, Lung, Stomach, and Uterus tumors, plus 12 tumor/normal pairs

T8235716d-5 Biochain 5 slides
EUR 606

cDNA - Plant Normal Tissue: cDNA - Plant: Corn

C1634330 Biochain 40 reactions
EUR 674

cDNA - Plant Normal Tissue: cDNA - Plant: Rice

C1634360 Biochain 40 reactions
EUR 674

cDNA - Plant Normal Tissue: cDNA - Plant: Wheat

C1634390 Biochain 40 reactions
EUR 674

cDNA - Plant Normal Tissue: cDNA - Plant: Orange

C1634340 Biochain 40 reactions
EUR 674

cDNA - Plant Normal Tissue: cDNA - Plant: Potato

C1634350 Biochain 40 reactions
EUR 674

cDNA - Plant Normal Tissue: cDNA - Plant: Arabidopsis

C1634310 Biochain 40 reactions
EUR 674

cDNA - Plant Normal Tissue: cDNA - Plant: Soy bean

C1634370 Biochain 40 reactions
EUR 674

Novo? cDNA Kit

M1165-100 Biovision each
EUR 424.8

Novo? cDNA Kit

M1165-25 Biovision each
EUR 320.4

cDNA - Lupus: Lung

C1236152Lup Biochain 40 reactions
EUR 737

cDNA - Lupus: Colon

C1236090Lup Biochain 40 reactions
EUR 737

cDNA - Lupus: Heart

C1236122Lup Biochain 40 reactions
EUR 737

cDNA - Lupus: Liver

C1236149Lup Biochain 40 reactions
EUR 737

cDNA - Asthma: Lung

C1236152Ld-1 Biochain 40 reactions
EUR 899

cDNA - Lupus: Kidney

C1236142Lup Biochain 40 reactions
EUR 737

cDNA - Lupus: Spleen

C1236246Lup Biochain 40 reactions
EUR 737

Evo? cDNA Supermix

M1168-100 Biovision each
EUR 457.2

Evo? cDNA Supermix

M1168-25 Biovision each
EUR 320.4

cDNA - Lupus: stomach

C1236248Lup Biochain 40 reactions
EUR 737

Novo? cDNA Supermix

M1169-100 Biovision each
EUR 529.2

Novo? cDNA Supermix

M1169-25 Biovision each
EUR 346.8

cDNA - Emphysema: Lung

C1236152Ld-3 Biochain 40 reactions
EUR 899

cDNA - Pneumonia: Lung

C1236152Ld-4 Biochain 40 reactions
EUR 899

cDNA - Lupus: Pancreas

C1236188Lup Biochain 40 reactions
EUR 737

First-Strand cDNA Synthesis SuperMix (cDNA up to 12 kb)

20-abx09801620ulSystems Abbexa
  • EUR 744.00
  • EUR 627.60
  • 100 rxns × 20 ul Systems
  • 50 rxns × 20 ul Systems

First-Strand cDNA Synthesis SuperMix (cDNA up to 15 kb)

20-abx09802120ulSystems Abbexa
  • EUR 1045.20
  • EUR 794.40
  • 100 rxns × 20 ul Systems
  • 50 rxns × 20 ul Systems

cDNA - Bronchitis: Lung

C1236152Ld-2 Biochain 40 reactions
EUR 899

cDNA - hypertension: Vein

C1236020Hd-2 Biochain 40 reactions
EUR 729

cDNA Synthesis SuperMix

20-abx09801420ulSystems Abbexa
  • EUR 678.00
  • EUR 577.20
  • 100 rxns × 20 ul Systems
  • 50 rxns × 20 ul Systems

cDNA - hypertension: Heart

C1236122Hd-2 Biochain 40 reactions
EUR 729

Evo™ cDNA Kit

M1164-100 Biovision each Ask for price

Evo™ cDNA Kit

M1164-25 Biovision each Ask for price

cDNA - hypertension: Artery

C1236013Hd-2 Biochain 40 reactions
EUR 729

cDNA - hypertension: Kidney

C1236142Hd-2 Biochain 40 reactions
EUR 729

cDNA - Arteriosclerosis: Aorta

C1236012Hd-4 Biochain 40 reactions
EUR 899

cDNA - Arteriosclerosis: Artery

C1236013Hd-4 Biochain 40 reactions
EUR 899

Human eNOS cDNA probe

eNOS51-D-2 Alpha Diagnostics 2 ug
EUR 534

cDNA - Lupus: Spinal Cord

C1236234Lup Biochain 40 reactions
EUR 737

Tetro cDNA Synthesis Kit

BIO-65042 Bioline 30 Reactions Ask for price

Tetro cDNA Synthesis Kit

BIO-65043 Bioline 100 Reactions Ask for price

EVery cDNA Synthesis Kit

EVery200B-1 SBI 20 preps
EUR 307

cDNA - Liver Cirrhosis: Lung

C1236152Lcs Biochain 40 reactions
EUR 729

cDNA - Liver Cirrhosis: Skin

C1236218Lcs Biochain 40 reactions
EUR 729

cDNA - Liver Cirrhosis: Brain

C1236035Lcs Biochain 40 reactions
EUR 729

cDNA - Liver Cirrhosis: Colon

C1236090Lcs Biochain 40 reactions
EUR 729

cDNA - Liver Cirrhosis: Heart

C1236122Lcs Biochain 40 reactions
EUR 729

cDNA - Liver Cirrhosis: Liver

C1236149Lcs Biochain 40 reactions
EUR 729

cDNA - Lupus: Small Intestine

C1236226Lup Biochain 40 reactions
EUR 737

circRNA cDNA Synthesis Kit

G627 ABM 25 rxn (20 ul/rxn)
EUR 370.8

cDNA Probe Diluent Solution

AR0063 BosterBio 5mL
EUR 127.2

cDNA - Liver Cirrhosis: Kidney

C1236142Lcs Biochain 40 reactions
EUR 729

cDNA - Liver Cirrhosis: Spleen

C1236246Lcs Biochain 40 reactions
EUR 729

Novo? Transcriptome cDNA Kit

M1167-100 Biovision each
EUR 1142.4

Novo? Transcriptome cDNA Kit

M1167-25 Biovision each
EUR 529.2

SensiFAST cDNA Synthesis Kit

BIO-65053 Bioline 50 Reactions Ask for price

SensiFAST cDNA Synthesis Kit

BIO-65053/S Bioline Sample Ask for price

SensiFAST cDNA Synthesis Kit

BIO-65054 Bioline 250 Reactions Ask for price

cDNA - Alzheimer's Disease: Brain

C1236035Alz Biochain 40 reactions
EUR 729

cDNA - Parkinson's Disease: Brain

C1236035Par Biochain 40 reactions
EUR 729

cDNA - Pulmonary Embolism: Lung

C1236152Ld-5 Biochain 40 reactions
EUR 899

cDNA - Liver Cirrhosis: Pancreas

C1236188Lcs Biochain 40 reactions
EUR 729

Plant Tissue cDNA: Arabidopsis

PC34-310 Alpha Diagnostics 10 rxn
EUR 498

cDNA - Liver Cirrhosis: Esophagus

C1236106Lcs Biochain 40 reactions
EUR 729

cDNA - Liver Cirrhosis: Diaphragm

C1236169Lcs Biochain 40 reactions
EUR 729

cDNA - Dementia: Brain: Hippocampus

C1236052Dem Biochain 40 reactions
EUR 886

OneScriptPlus cDNA Synthesis Kit

G235 ABM 25 x 20 ul reactions
EUR 116.4

OneScriptPlus cDNA Synthesis Kit

G236 ABM 100 x 20 ul reactions
EUR 202.8

cDNA - Depression: Brain: Hippocampus

C1236052Dep Biochain 40 reactions
EUR 886

Evo? cDNA Kit (gDNA Removal)

M1166-100 Biovision each
EUR 457.2

cDNA - Lupus: Liver: Left Lobe

C1236150Lup Biochain 40 reactions
EUR 737

cDNA - Rat Normal Tissue: Lung

C1434152 Biochain 40 reactions
EUR 385

cDNA - Dog Normal Tissue: Lung

C1734152 Biochain 40 reactions
EUR 385

cDNA - Lupus: Liver: Right Lobe

C1236151Lup Biochain 40 reactions
EUR 737

cDNA - Rat Normal Tissue: Brain

C1434035 Biochain 40 reactions
EUR 385

cDNA - Rat Normal Tissue: Colon

C1434090 Biochain 40 reactions
EUR 578

cDNA - Rat Normal Tissue: Heart

C1434122 Biochain 40 reactions
EUR 385

cDNA - Rat Normal Tissue: Liver

C1434149 Biochain 40 reactions
EUR 385

cDNA - Dog Normal Tissue: Brain

C1734035 Biochain 40 reactions
EUR 385

cDNA - Dog Normal Tissue: Cecum

C1734089 Biochain 40 reactions
EUR 385

cDNA - Dog Normal Tissue: Heart

C1734122 Biochain 40 reactions
EUR 385

cDNA - Dog Normal Tissue: Liver

C1734149 Biochain 40 reactions
EUR 385

cDNA - Human Tumor Tissue: Bone

C1235023-10 Biochain 10 reactions
EUR 274

cDNA - Human Tumor Tissue: Lung

C1235152 Biochain 40 reactions
EUR 578

cDNA - Human Tumor Tissue: Nose

C1235178-10 Biochain 10 reactions
EUR 274

cDNA - Human Tumor Tissue: Skin

C1235218-10 Biochain 10 reactions
EUR 274

Human Adult cDNA Tissue: Lung

HA-152 Alpha Diagnostics 10 rxn
EUR 498

Human Adult cDNA Tissue: Skin

HA-218 Alpha Diagnostics 10 rxn
EUR 498

OneScriptPlus cDNA Synthesis SuperMix

G453 ABM 25 x 20 ul reactions
EUR 116.4

OneScriptPlus cDNA Synthesis SuperMix

G454 ABM 100 x 20 ul reactions
EUR 202.8

cDNA - Rat Normal Tissue: Kidney

C1434142 Biochain 40 reactions
EUR 385

cDNA - Rat Normal Tissue: Rectum

C1434206 Biochain 40 reactions
EUR 578

cDNA - Rat Normal Tissue: Spleen

C1434246 Biochain 40 reactions
EUR 385

cDNA - Rat Normal Tissue: Testis

C1434260 Biochain 40 reactions
EUR 385

cDNA - Dog Normal Tissue: Kidney

C1734142 Biochain 40 reactions
EUR 385

cDNA - Dog Normal Tissue: Rectum

C1734206 Biochain 40 reactions
EUR 385

cDNA - Dog Normal Tissue: Testis

C1734260 Biochain 40 reactions
EUR 385

cDNA - Mouse Normal Tissue: Lung

C1334152 Biochain 40 reactions
EUR 385

cDNA - Human Tumor Tissue: Brain

C1235035-10 Biochain 10 reactions
EUR 274

cDNA - Human Tumor Tissue: Colon

C1235090 Biochain 40 reactions
EUR 578

cDNA - Human Tumor Tissue: Liver

C1235149 Biochain 40 reactions
EUR 578

cDNA - Human Tumor Tissue: Ovary

C1235183-10 Biochain 10 reactions
EUR 525

cDNA - Rat Normal Tissue: Adipose

C1434003 Biochain 40 reactions
EUR 578

cDNA - Rat Normal Tissue: Bladder

C1434010 Biochain 40 reactions
EUR 385

cDNA - Rat Normal Tissue: Stomach

C1434248 Biochain 40 reactions
EUR 385

cDNA - Dog Normal Tissue: Bladder

C1734010 Biochain 40 reactions
EUR 385

cDNA - Dog Normal Tissue: Trachea

C1734160 Biochain 40 reactions
EUR 385

cDNA - Dog Normal Tissue: Stomach

C1734248 Biochain 40 reactions
EUR 385

cDNA - Mouse Normal Tissue: Brain

C1334035 Biochain 40 reactions
EUR 385

cDNA - Mouse Normal Tissue: Colon

C1334090 Biochain 40 reactions
EUR 578

cDNA - Mouse Normal Tissue: Heart

C1334122 Biochain 40 reactions
EUR 385

cDNA - Mouse Normal Tissue: Liver

C1334149 Biochain 40 reactions
EUR 385

cDNA - Human Tumor Tissue: Breast

C1235086 Biochain 40 reactions
EUR 578

cDNA - Human Tumor Tissue: Kidney

C1235142 Biochain 40 reactions
EUR 578
×

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Compare rec. lab reagents for research
  • Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.
  • Engineering hybrid genes without the use of restriction enzymes: gene splicing
  • Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
  • Supervised risk predictor of breast cancer based on intrinsic subtypes.

Recent Comments

    Categories

    • antibody
    • cDNA
    • elisa kits
    • Isotype
    • Lenti
    • pcr
    • peptide
    • rna
    • Uncategorized
    • vector
    September 2023
    M T W T F S S
     123
    45678910
    11121314151617
    18192021222324
    252627282930  
    « Dec    

    Categories

    • antibody
    • cDNA
    • elisa kits
    • Isotype
    • Lenti
    • pcr
    • peptide
    • rna
    • Uncategorized
    • vector

    Recent Posts

    • Compare rec. lab reagents for research
    • Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.
    • Engineering hybrid genes without the use of restriction enzymes: gene splicing
    • Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
    • Supervised risk predictor of breast cancer based on intrinsic subtypes.
    © 2023 International Union of Quaternary Research (INQUA), INQUA – Commission on Stratigraphy and Chronology (SACCOM) | Powered by Superbs Personal Blog theme